<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p65" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_65{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_65{left:341px;bottom:30px;}
#t3_65{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_65{left:377px;bottom:30px;}
#t5_65{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_65{left:540px;bottom:30px;}
#t7_65{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_65{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_65{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_65{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_65{left:285px;bottom:827px;letter-spacing:-0.36px;word-spacing:0.11px;}
#tc_65{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_65{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_65{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_65{left:1115px;bottom:28px;letter-spacing:0.3px;}
#tg_65{left:37px;bottom:216px;}
#th_65{left:48px;bottom:210px;letter-spacing:0.12px;}
#ti_65{left:521px;bottom:210px;letter-spacing:0.16px;}
#tj_65{left:46px;bottom:193px;letter-spacing:0.11px;word-spacing:-0.04px;}
#tk_65{left:360px;bottom:193px;}
#tl_65{left:37px;bottom:182px;}
#tm_65{left:43px;bottom:176px;letter-spacing:0.12px;}
#tn_65{left:46px;bottom:160px;letter-spacing:0.12px;}
#to_65{left:46px;bottom:143px;letter-spacing:0.11px;}
#tp_65{left:46px;bottom:126px;letter-spacing:0.12px;}
#tq_65{left:252px;bottom:126px;letter-spacing:0.06px;word-spacing:0.09px;}
#tr_65{left:37px;bottom:115px;}
#ts_65{left:47px;bottom:109px;letter-spacing:0.13px;}
#tt_65{left:262px;bottom:109px;}
#tu_65{left:36px;bottom:778px;letter-spacing:0.25px;}
#tv_65{left:188px;bottom:778px;letter-spacing:0.29px;word-spacing:-0.13px;}
#tw_65{left:383px;bottom:786px;}
#tx_65{left:558px;bottom:778px;letter-spacing:0.28px;word-spacing:-0.12px;}
#ty_65{left:766px;bottom:786px;}
#tz_65{left:920px;bottom:778px;letter-spacing:0.34px;}
#t10_65{left:1065px;bottom:590px;letter-spacing:-0.09px;}
#t11_65{left:1065px;bottom:572px;letter-spacing:-0.06px;}
#t12_65{left:1065px;bottom:553px;letter-spacing:-0.09px;}
#t13_65{left:1065px;bottom:535px;letter-spacing:-0.09px;}
#t14_65{left:1065px;bottom:517px;letter-spacing:-0.25px;}
#t15_65{left:913px;bottom:572px;letter-spacing:-0.1px;}
#t16_65{left:913px;bottom:553px;letter-spacing:-0.09px;}
#t17_65{left:913px;bottom:535px;letter-spacing:-0.08px;}
#t18_65{left:191px;bottom:336px;letter-spacing:-0.16px;word-spacing:-0.02px;}
#t19_65{left:36px;bottom:656px;letter-spacing:-0.11px;}
#t1a_65{left:36px;bottom:336px;letter-spacing:-0.11px;}
#t1b_65{left:36px;bottom:465px;letter-spacing:-0.11px;}
#t1c_65{left:188px;bottom:666px;letter-spacing:-0.1px;}
#t1d_65{left:188px;bottom:648px;letter-spacing:-0.1px;}
#t1e_65{left:263px;bottom:655px;letter-spacing:-0.12px;}
#t1f_65{left:187px;bottom:485px;letter-spacing:-0.1px;}
#t1g_65{left:267px;bottom:492px;}
#t1h_65{left:187px;bottom:467px;letter-spacing:-0.09px;}
#t1i_65{left:187px;bottom:448px;letter-spacing:-0.1px;}
#t1j_65{left:270px;bottom:456px;}
#t1k_65{left:363px;bottom:729px;letter-spacing:-0.1px;}
#t1l_65{left:363px;bottom:710px;letter-spacing:-0.09px;}
#t1m_65{left:363px;bottom:692px;letter-spacing:-0.09px;}
#t1n_65{left:428px;bottom:700px;}
#t1o_65{left:363px;bottom:611px;letter-spacing:-0.1px;}
#t1p_65{left:363px;bottom:593px;letter-spacing:-0.09px;}
#t1q_65{left:363px;bottom:575px;letter-spacing:-0.09px;}
#t1r_65{left:428px;bottom:582px;}
#t1s_65{left:558px;bottom:747px;letter-spacing:-0.13px;}
#t1t_65{left:581px;bottom:755px;}
#t1u_65{left:558px;bottom:729px;letter-spacing:-0.06px;}
#t1v_65{left:558px;bottom:710px;letter-spacing:-0.21px;word-spacing:-0.06px;}
#t1w_65{left:798px;bottom:718px;letter-spacing:-0.12px;}
#t1x_65{left:558px;bottom:692px;letter-spacing:-0.09px;}
#t1y_65{left:558px;bottom:674px;letter-spacing:-0.09px;}
#t1z_65{left:558px;bottom:622px;letter-spacing:-0.13px;}
#t20_65{left:581px;bottom:629px;letter-spacing:-0.07px;}
#t21_65{left:601px;bottom:622px;letter-spacing:-0.09px;}
#t22_65{left:558px;bottom:604px;letter-spacing:-0.09px;}
#t23_65{left:558px;bottom:585px;letter-spacing:-0.1px;}
#t24_65{left:558px;bottom:567px;letter-spacing:-0.09px;}
#t25_65{left:363px;bottom:526px;letter-spacing:-0.1px;}
#t26_65{left:363px;bottom:508px;letter-spacing:-0.09px;}
#t27_65{left:363px;bottom:490px;letter-spacing:-0.09px;}
#t28_65{left:428px;bottom:497px;}
#t29_65{left:363px;bottom:432px;letter-spacing:-0.1px;}
#t2a_65{left:363px;bottom:414px;letter-spacing:-0.09px;}
#t2b_65{left:363px;bottom:395px;letter-spacing:-0.09px;}
#t2c_65{left:428px;bottom:403px;}
#t2d_65{left:558px;bottom:536px;letter-spacing:-0.13px;}
#t2e_65{left:581px;bottom:543px;letter-spacing:-0.1px;}
#t2f_65{left:558px;bottom:517px;letter-spacing:-0.1px;}
#t2g_65{left:558px;bottom:499px;letter-spacing:-0.1px;}
#t2h_65{left:801px;bottom:506px;letter-spacing:-0.12px;}
#t2i_65{left:558px;bottom:481px;letter-spacing:-0.1px;}
#t2j_65{left:558px;bottom:414px;letter-spacing:-0.13px;}
#t2k_65{left:581px;bottom:421px;letter-spacing:-0.1px;}
#t2l_65{left:602px;bottom:414px;letter-spacing:-0.1px;}
#t2m_65{left:675px;bottom:198px;}
#t2n_65{left:681px;bottom:192px;letter-spacing:0.13px;word-spacing:-0.06px;}
#t2o_65{left:961px;bottom:192px;}
#t2p_65{left:675px;bottom:182px;}
#t2q_65{left:689px;bottom:176px;letter-spacing:0.13px;word-spacing:-0.04px;}
#t2r_65{left:684px;bottom:159px;letter-spacing:0.03px;}
#t2s_65{left:749px;bottom:159px;}
#t2t_65{left:675px;bottom:148px;}
#t2u_65{left:686px;bottom:142px;letter-spacing:0.12px;}
#t2v_65{left:1119px;bottom:142px;letter-spacing:0.15px;}
#t2w_65{left:1167px;bottom:142px;}
#t2x_65{left:675px;bottom:131px;}
#t2y_65{left:686px;bottom:125px;letter-spacing:0.12px;}
#t2z_65{left:684px;bottom:108px;letter-spacing:0.12px;}
#t30_65{left:829px;bottom:108px;letter-spacing:0.13px;}
#t31_65{left:913px;bottom:108px;}
#t32_65{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_65{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_65{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_65{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_65{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_65{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_65{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_65{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s7_65{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s8_65{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s9_65{font-size:15px;font-family:ArialMT_k0;color:#000;}
.sa_65{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.sb_65{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sc_65{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.sd_65{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts65" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: ArialMT_k0;
	src: url("fonts/ArialMT_k0.woff") format("woff");
}

</style>
<div id="pg65Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg65" style="-webkit-user-select: none;"><object width="1210" height="935" data="65/65.svg" type="image/svg+xml" id="pdf65" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_65" class="t s0_65">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_65" class="t s1_65">® </span>
<span id="t3_65" class="t s0_65">(NCCN </span>
<span id="t4_65" class="t s1_65">® </span>
<span id="t5_65" class="t s0_65">), All rights reserved. NCCN Guidelines </span>
<span id="t6_65" class="t s1_65">® </span>
<span id="t7_65" class="t s0_65">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_65" class="t s2_65">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_65" class="t s2_65">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_65" class="t s3_65">NCCN Guidelines Version 4.2024 </span>
<span id="tb_65" class="t s3_65">Maxillary Sinus Tumors </span>
<span id="tc_65" class="t s4_65">NCCN Guidelines Index </span>
<span id="td_65" class="t s4_65">Table of Contents </span>
<span id="te_65" class="t s4_65">Discussion </span>
<span id="tf_65" class="t s5_65">MAXI-3 </span>
<span id="tg_65" class="t s6_65">h </span>
<span id="th_65" class="t s7_65">See the salivary gland algorithm for management after resection. See </span><span id="ti_65" class="t s8_65">NCCN </span>
<span id="tj_65" class="t s8_65">Guidelines for Salivary Gland Tumors (SALI-1)</span><span id="tk_65" class="t s7_65">. </span>
<span id="tl_65" class="t s6_65">j </span>
<span id="tm_65" class="t s7_65">For SNUC with neuroendocrine features, small cell, high-grade olfactory </span>
<span id="tn_65" class="t s7_65">esthesioneuroblastoma, or SNEC histologies, systemic therapy should be a part of the </span>
<span id="to_65" class="t s7_65">overall treatment. Consider a clinical trial and referral to a major medical center that </span>
<span id="tp_65" class="t s9_65">specializes in these diseases. </span><span id="tq_65" class="t s8_65">See SYST-A. </span>
<span id="tr_65" class="t s6_65">k </span>
<span id="ts_65" class="t s8_65">Principles of Surgery (SURG-A)</span><span id="tt_65" class="t s7_65">. </span>
<span id="tu_65" class="t s5_65">STAGING </span><span id="tv_65" class="t s5_65">PRIMARY TREATMENT </span>
<span id="tw_65" class="t sa_65">j </span>
<span id="tx_65" class="t s5_65">ADJUVANT TREATMENT </span>
<span id="ty_65" class="t sa_65">j </span>
<span id="tz_65" class="t s5_65">FOLLOW-UP </span>
<span id="t10_65" class="t s5_65">Recurrent </span>
<span id="t11_65" class="t s5_65">or </span>
<span id="t12_65" class="t s5_65">Persistent </span>
<span id="t13_65" class="t s5_65">Disease </span>
<span id="t14_65" class="t sb_65">(ADV-3) </span>
<span id="t15_65" class="t s5_65">Follow-up </span>
<span id="t16_65" class="t sb_65">(FOLL-A, 1 </span>
<span id="t17_65" class="t sb_65">of 2) </span>
<span id="t18_65" class="t sb_65">Treatment of Very Advanced Head and Neck Cancer (ADV-1) </span>
<span id="t19_65" class="t s5_65">T3–T4a,N0 </span>
<span id="t1a_65" class="t s5_65">T4b,N0–3 </span>
<span id="t1b_65" class="t s5_65">T1–T4a,N+ </span>
<span id="t1c_65" class="t s5_65">Complete </span>
<span id="t1d_65" class="t s5_65">resection </span>
<span id="t1e_65" class="t sa_65">h,k </span>
<span id="t1f_65" class="t s5_65">Resection </span>
<span id="t1g_65" class="t sa_65">h </span>
<span id="t1h_65" class="t s5_65">+ neck </span>
<span id="t1i_65" class="t s5_65">dissection </span>
<span id="t1j_65" class="t sa_65">k </span>
<span id="t1k_65" class="t s5_65">Adverse </span>
<span id="t1l_65" class="t s5_65">pathologic </span>
<span id="t1m_65" class="t s5_65">features </span>
<span id="t1n_65" class="t sa_65">o </span>
<span id="t1o_65" class="t s5_65">No adverse </span>
<span id="t1p_65" class="t s5_65">pathologic </span>
<span id="t1q_65" class="t s5_65">features </span>
<span id="t1r_65" class="t sa_65">o </span>
<span id="t1s_65" class="t s5_65">RT </span>
<span id="t1t_65" class="t sa_65">l </span>
<span id="t1u_65" class="t s5_65">or </span>
<span id="t1v_65" class="t s5_65">Consider systemic therapy/RT </span>
<span id="t1w_65" class="t sa_65">l,m </span>
<span id="t1x_65" class="t s5_65">(category 2B) to primary and </span>
<span id="t1y_65" class="t s5_65">neck </span>
<span id="t1z_65" class="t s5_65">RT </span>
<span id="t20_65" class="t sa_65">l,n </span>
<span id="t21_65" class="t s5_65">to primary and neck </span>
<span id="t22_65" class="t s5_65">(category 2B for neck for </span>
<span id="t23_65" class="t sc_65">squamous cell carcinoma and </span>
<span id="t24_65" class="t sc_65" data-mappings='[[4,"ff"]]'>undiﬀerentiated tumors) </span>
<span id="t25_65" class="t s5_65">Adverse </span>
<span id="t26_65" class="t s5_65">pathologic </span>
<span id="t27_65" class="t s5_65">features </span>
<span id="t28_65" class="t sa_65">o </span>
<span id="t29_65" class="t s5_65">No adverse </span>
<span id="t2a_65" class="t s5_65">pathologic </span>
<span id="t2b_65" class="t s5_65">features </span>
<span id="t2c_65" class="t sa_65">o </span>
<span id="t2d_65" class="t s5_65">RT </span>
<span id="t2e_65" class="t sa_65">l,n </span>
<span id="t2f_65" class="t s5_65">or </span>
<span id="t2g_65" class="t s5_65">Consider systemic therapy/RT </span>
<span id="t2h_65" class="t sa_65">l,m </span>
<span id="t2i_65" class="t s5_65">to primary and neck (category 2B) </span>
<span id="t2j_65" class="t s5_65">RT </span>
<span id="t2k_65" class="t sa_65">l,n </span>
<span id="t2l_65" class="t s5_65">to primary + neck </span>
<span id="t2m_65" class="t s6_65">l </span>
<span id="t2n_65" class="t s8_65">Principles of Radiation Therapy (MAXI-A)</span><span id="t2o_65" class="t s7_65">. </span>
<span id="t2p_65" class="t s6_65">m </span>
<span id="t2q_65" class="t s8_65">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers </span>
<span id="t2r_65" class="t s8_65">(SYST-A)</span><span id="t2s_65" class="t s7_65">. </span>
<span id="t2t_65" class="t s6_65">n </span>
<span id="t2u_65" class="t s7_65">For adenoid cystic tumors and minor salivary gland tumors, see </span><span id="t2v_65" class="t s8_65">SALI-A</span><span id="t2w_65" class="t s7_65">. </span>
<span id="t2x_65" class="t s6_65">o </span>
<span id="t2y_65" class="t s7_65">Adverse pathologic features: positive margins, close margins, or </span>
<span id="t2z_65" class="t s7_65">extranodal extension </span><span id="t30_65" class="t s8_65">(Discussion)</span><span id="t31_65" class="t s7_65">. </span>
<span id="t32_65" class="t sd_65">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
